CCA
ELV icon

Criterion Capital Advisors’s Elevance Health ELV Stock Holding History

Criterion Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$3.79K Hold
7
– – ﹤0.01% 300
2024
Q3 		$3.79K Hold
7
– – ﹤0.01% 300
2024
Q2 		$3.79K Hold
7
– – ﹤0.01% 300
2024
Q1 		$3.63K Hold
7
– – ﹤0.01% 300
2023
Q4 		$3.3K Buy
+7
New +$3.24K ﹤0.01% 311

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Criterion Capital Advisors's ELV Position: Q4 2024 in Review

Criterion Capital Advisors held its Elevance Health (ELV) position steady in Q4 2024 at 7 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #300.

Criterion Capital Advisors first reported a position in ELV in Q4 2023 and has held it in 5 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Criterion Capital Advisors held 7 shares of Elevance Health worth $3.79K as of Q4 2024.
  • Criterion Capital Advisors left its Elevance Health share count unchanged in Q4 2024.
  • Elevance Health made up ﹤0.01% of Criterion Capital Advisors's portfolio in Q4 2024, its #300 holding.
  • Criterion Capital Advisors first reported a position in Elevance Health in Q4 2023 and has held it in 5 quarters since.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.